Zhuo, Jia Long <br/><br/>
Perindopril alters vascular angiotensin-converting enzyme, AT(1) receptor, and nitric oxide synthase expression in patients with coronary heart disease.  [electronic resource] 

 -  Hypertension (Dallas, Tex. : 1979)  Feb 2002 
 - 634-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1524-4563 
<br/><br/><label>Standard No.: </label>10.1161/hy0202.103417  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Angiotensin-Converting Enzyme Inhibitors--pharmacology<br/>Angiotensins--blood<br/>Autoradiography<br/>Coronary Disease--enzymology<br/>Endothelium, Vascular--drug effects<br/>Female<br/>Gene Expression--drug effects<br/>Humans<br/>Immunohistochemistry<br/>Male<br/>Middle Aged<br/>Nitric Oxide Synthase--biosynthesis<br/>Nitric Oxide Synthase Type II<br/>Nitric Oxide Synthase Type III<br/>Peptidyl-Dipeptidase A--biosynthesis<br/>Perindopril--pharmacology<br/>Receptor, Angiotensin, Type 1<br/>Receptor, Angiotensin, Type 2<br/>Receptors, Angiotensin--biosynthesis